BioGems
BioGems is an innovative biotechnology company with a focus on developing and marketing innovative technologies that improve global health. Founded with the mission to accelerate discoveries in life sciences to promote a healthier world, the company provides products and services that help researchers to study, predict, and prevent diseases. Prize-winning research is powering the development of BioGems' product pipeline, such as MAB IL-20 RECP 2 (IL-20RB), a monoclonal antibody (mAb) designed to reduce the risk of infection, inflammation, and other serious complications associated with immunotherapy treatments.BioGems products are used by research labs, research institutions, and healthcare facilities. Our unique selling points include a hassle-free ordering experience, complete technical support, prompt and safety-oriented shipping, and a robust product portfolio. BioGems helps researchers get the answers they need quickly, so they can focus their resources on improving life expectancy and reducing preventable deaths.